insights_auto
Why is GH up 2,50%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
166,66 $
arrow_upward
+2,50%(+4,07) 1D
166,66 $
0,00% (0,00)
bedtimeAfter hours
Closed: 21 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
162,29 $
High
171,22 $
Low
162,00 $
Mkt. cap
22,37 млрд
Avg. vol.
1,78 млн
Volume
2,53 млн
52-wk high
191,01 $
52-wk low
66,59 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 мың
Open
162,29 $
High
171,22 $
Low
162,00 $
Mkt. cap
22,37 млрд
Avg. vol.
1,78 млн
Volume
2,53 млн
52-wk high
191,01 $
52-wk low
66,59 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 млн
No. of employees
2 мың
News stories
From web sources and news partners
Zacks
·
6 сағат бұрын
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Stock Titan
·
1 күн бұрын
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
MarketBeat
·
2 күн бұрын
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 мың
Founded2012
HeadquartersПало Альто, Калифорния, Америка Құрама Штаттары
SectorHealth care provider
Websiteguardanthealth.com